Related Experiment Videos
Nanobiohybrids as delivery vehicles for camptothecin
Katherine M Tyner1, Scott R Schiffman, Emmanuel P Giannelis
1Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.
Summary
This study introduces a new method for delivering poorly soluble drugs like camptothecin using layered double hydroxide (LDH) nanoparticles. This nanobiohybrid drug delivery system enhances drug solubility and shows promise for cancer therapy.
Area of Science:
- Materials Science
- Nanotechnology
- Drug Delivery
Background:
- Poorly water-soluble drugs present significant challenges in pharmaceutical development.
- Developing effective drug delivery systems is crucial for improving therapeutic outcomes.
Purpose of the Study:
- To develop a novel nanobiohybrid system for delivering non-ionic, poorly water-soluble drugs.
- To enhance the solubility and efficacy of camptothecin using layered double hydroxides (LDHs).
Main Methods:
- Camptothecin was incorporated into micelles from negatively charged surfactants.
- Micelles were encapsulated into magnesium-aluminum layered double hydroxides (LDHs) via ion exchange.
- Drug release kinetics and in vitro cytotoxicity were evaluated.
Main Results:
- The nanobiohybrid demonstrated a threefold increase in camptothecin solubility.
- Rapid drug release was observed within 10 minutes at pH 4.8 and 7.2.
- In vitro studies showed significantly reduced glioma cell survival with the camptothecin nanobiohybrid.
Conclusions:
- The developed nanobiohybrid system effectively delivers poorly soluble drugs.
- LDH-based nanocarriers offer potential for enhanced drug solubility and targeted delivery.
- This approach holds promise for various drug therapies, particularly in oncology.